Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

WVE

Wave Life Sciences Ltd

Apr 28 • 04:00PM ET

7.52

+0.58 8.36 %

Healthcare • Biotechnology • Singapore • Small • NASD

Apr 28, 5:38 PMWave Life Sciences accelerates obesity and AATD programs as Q1 2026 revenue jumps to $38.2M, extending cash runway into 3Q 2028

Peers: IONS ALNY SRPT ARWR MRNA NBIX VRTX BIIB QURE EDIT

| Held by: IWM VXF IBB IWO VTWO SCHA XPH IHE IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.21	Insider Own	17.95%	Shs Outstand	187.66M	Perf Week	2.45%
Market Cap	1.42B	Forward P/E	-	EPS next Y	-1.30	Insider Trans	37.10%	Shs Float	154.47M	Perf Month	18.15%
Enterprise Value	839.25M	PEG	-	EPS next Q	-0.31	Inst Own	90.71%	Short Float	8.64%	Perf Quarter	-43.71%
Income	-204.38M	P/S	33.13	EPS this Y	2.72%	Inst Trans	15.16%	Short Ratio	3.14	Perf Half Y	5.47%
Sales	42.73M	P/B	2.72	EPS next Y	-10.85%	ROA	-41.26%	Short Interest	13.35M	Perf YTD	-55.76%
Book/sh	2.76	P/C	2.35	EPS next 5Y	2.26%	ROE	-54.97%	52W High	21.73 -65.39%	Perf Year	10.10%
Cash/sh	3.20	P/FCF	-	EPS past 3/5Y	16.10% 20.52%	ROIC	-38.16%	52W Low	5.02 49.80%	Perf 3Y	88.47%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	127.08% 16.31%	Gross Margin	79.28%	Volatility	4.93% 5.90%	Perf 5Y	21.68%
Dividend TTM	-	EV/Sales	19.64	EPS Y/Y TTM	-54.80%	Oper. Margin	-504.09%	ATR (14)	0.58	Perf 10Y	-43.88%
Dividend Ex-Date	-	Quick Ratio	6.47	Sales Y/Y TTM	-60.55%	Profit Margin	-478.33%	RSI (14)	40.84	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	6.47	EPS Q/Q	-273.85%	SMA20	3.52%	Beta	-1.34	Target Price	25.22
Payout	-	Debt/Eq	0.03	Sales Q/Q	-79.41%	SMA50	-27.58%	Rel Volume	1.63	Prev Close	6.94
Employees	317	LT Debt/Eq	0.02	Earnings	Apr 28 BMO	SMA200	-26.39%	Avg Volume	4.25M	Price	7.52
IPO	Nov 11, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.81% 352.57%	Trades		Volume	6,937,720	Change	8.36%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-05-26	Initiated	BofA Securities	Buy	$38
Dec-12-25	Reiterated	Wedbush	Outperform	$20 → $33
Dec-09-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$27
Oct-20-25	Initiated	Wells Fargo	Overweight	$18
Aug-04-25	Initiated	Canaccord Genuity	Buy	$19
Jul-28-25	Initiated	Oppenheimer	Outperform	$24
Jul-16-25	Initiated	Citigroup	Buy	$16
Jun-11-25	Resumed	Raymond James	Outperform	$14
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$10
Apr-08-25	Initiated	Wedbush	Outperform	$18
Feb-25-25	Initiated	Jefferies	Buy	$26
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$22
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20

Show Previous Ratings

Apr-28-26 07:37AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press) +8.36%
07:30AM	Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
Apr-22-26 08:30AM	Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 (GlobeNewswire)
Apr-21-26 04:01PM	Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States (GlobeNewswire)
Apr-15-26 04:01PM	Wave Life Sciences Announces Proposed Redomiciliation to the United States (GlobeNewswire)
01:45PM	Loading…
Apr-03-26 01:45PM	Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors (Barrons.com)
Mar-27-26 08:35AM	Waves stock crashes 50% on Phase I obesity data (Clinical Trials Arena)
Mar-26-26 02:48PM	Dow dips, Nasdaq falls as oil surges, Trump says Iran 'better get serious' (Proactive) -49.59%
12:30PM	Wave Life Sciences shares plummet on weight loss therapy update (Proactive)
09:40AM	Wave Plunges More Than 50% After Obesity Shot Falls Short (Bloomberg)
09:40AM	Wave Life Sciences Crashes 56% As 'Body Composition' Fat-Loss Drug Underwhelms (Investor's Business Daily)
07:30AM	Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 (GlobeNewswire)
06:46AM	Wave crashes on obesity drug update; Kodiaks reboot pays dividends (BioPharma Dive)
Mar-05-26 08:30AM	Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference (GlobeNewswire)
Mar-02-26 07:05AM	Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near (MarketBeat)
01:26PM	Loading…
Feb-28-26 01:26PM	Wave Life Sciences Ltd. (WVE): A Bull Case Theory (Insider Monkey)
02:14AM	Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings (Insider Monkey)
Feb-27-26 12:39PM	WAVE Life Sciences Q4 Earnings Call Highlights (MarketBeat) -9.31%
Feb-26-26 04:09PM	WAVE Life Sciences Ltd (WVE) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline with ... (GuruFocus.com) +5.64%
12:15PM	Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Wave Life Sciences Ltd. Q4 2025 Earnings Call Summary (Moby)
07:49AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire)
Feb-23-26 08:30AM	Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Feb-22-26 06:15AM	Bank of America Predicts Up to 240% Jump for These 2 Strong Buy Stocks (TipRanks)
Feb-19-26 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026 (GlobeNewswire)
Feb-18-26 07:38PM	Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment (Insider Monkey)
02:02AM	BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)'s Growth, Projecting Peak Sales Above $11B (Insider Monkey)
Feb-16-26 12:23PM	Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program (Insider Monkey)
Feb-07-26 03:33AM	Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment (Insider Monkey)
10:12AM	Loading…
Feb-05-26 10:12AM	Microsoft downgraded, Snap upgraded: Wall Street's top analyst calls (The Fly)
Feb-03-26 12:30PM	Wave Life Sciences price target raised to $50 from $47 at Clear Street (TipRanks)
Feb-02-26 02:16PM	Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path (Benzinga)
07:30AM	Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
03:31AM	GSK walks away from pioneering Wave RNA editing drug (BioPharma Dive)
Jan-12-26 07:30AM	Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (GlobeNewswire)
Jan-06-26 04:28PM	Arrowhead Says Its Gene Silencer Doubled Zepbound's Weight Loss (Investor's Business Daily)
11:26AM	Zepbound Boost Gets a Lift From Arrowhead's Drug. The Question Is Whether Patients Will Pay. (Barrons.com)
07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks)
Jan-05-26 08:30AM	Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.96%
Jan-02-26 10:50AM	Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target (Insider Monkey) -6.18%
Dec-31-25 11:25AM	Wave Life Sciences' (WVE) RNA Obesity Drug WVE-007 Shows Potential to Match GLP-1 Efficacy Without Muscle Loss (Insider Monkey)
Dec-30-25 11:46PM	H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) (Insider Monkey)
Dec-22-25 10:18PM	Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial (Insider Monkey) +12.45%
Dec-17-25 09:45AM	Share Offerings Prompt Huge Insider Buying in These 3 Biotechs (24/7 Wall St.)
Dec-14-25 02:40PM	Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial (Insider Monkey)
Dec-11-25 04:28PM	Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss (Investor's Business Daily) -17.20%
10:15AM	WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? (Zacks)
07:13AM	Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7% (Investor's Business Daily)
Dec-10-25 05:27PM	Golden Cross Alert: 3 Stocks With Major Upside Potential (MarketBeat) -5.07%
Dec-09-25 09:50PM	Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +15.06%
07:39PM	Why Wave Life Sciences Stock Crushed it Again Today (Motley Fool)
02:24PM	Wave Life Sciences (WVE) Soars to 6-Year High on Obesity Drug Clinical Trial (Insider Monkey)
Dec-08-25 06:50PM	Why Wave Life Sciences Stock Vaulted 146% Higher on Monday (Motley Fool) +147.26%
05:01PM	Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More (Motley Fool)
04:51PM	Wave Life Sciences Ltd. (WVE): A Bull Case Theory (Insider Monkey)
04:09PM	Wave Life Sciences Just Targeted Fat Loss, Specifically. Shares Skyrocketed 115%. (Investor's Business Daily)
04:01PM	Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire)
03:44PM	Wave Life skyrockets on obesity drug trial, Strategy buys bitcoin (Yahoo Finance Video)
12:46PM	Obesity Biotechs' Gains Hit Shares of Eli Lilly, Novo Nordisk (Barrons.com)
07:30AM	Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss (GlobeNewswire)
05:32AM	Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar (BioPharma Dive)
Dec-07-25 04:00PM	Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025 (GlobeNewswire)
Nov-16-25 10:13PM	Jefferies Maintains "Buy" Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning (Insider Monkey)
Nov-13-25 06:00AM	WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: Promising Clinical Advances and ... (GuruFocus.com)
Nov-10-25 08:45AM	Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -10.31%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Nov-07-25 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-06-25 07:00PM	CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-04-25 08:30PM	Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek 2025 (GlobeNewswire)
08:30AM	Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025 (GlobeNewswire)
Oct-30-25 05:53AM	Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? (Zacks)
Oct-29-25 10:50PM	Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day (GlobeNewswire) +8.83%
04:15PM	Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day (GlobeNewswire)
03:42PM	Wave Life Sciences stock soars after promising clinical data (Investing.com)
Oct-10-25 09:57AM	Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? (Zacks) -7.20%
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
08:30AM	Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-05-25 09:30AM	B. Riley aggressive buyer of Wave Life on material disconnect (TipRanks)
Sep-03-25 07:48AM	Wave shares sink on new study results for RNA editing drug (BioPharma Dive) -16.84%
07:30AM	Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Aug-29-25 05:09AM	Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins (Insider Monkey)
Aug-03-25 06:25AM	Oppenheimer Predicts Up to 590% Rally for These 2 Strong Buy Stocks (TipRanks)
Jul-31-25 05:01AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ... (GuruFocus.com)
Jul-30-25 09:00AM	Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Jul-29-25 09:48AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-24-25 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-23-25 08:30AM	Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 (GlobeNewswire) +7.94%
Jul-15-25 08:59AM	Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions (Insider Monkey)
Jul-11-25 11:27AM	Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 (Insider Monkey)
Jul-03-25 09:18AM	H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release (Insider Monkey)
Jun-20-25 04:01PM	Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions (GlobeNewswire) +5.94%
Jun-11-25 09:45AM	Raymond James bullish on biotech firms on favorable valuation (Investing.com)
May-29-25 08:30AM	Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-28-25 08:00AM	Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer (GlobeNewswire)
May-13-25 08:45AM	Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? (Insider Monkey)
May-09-25 03:18AM	WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... (GuruFocus.com)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 26 '26	Buy	6.08	5,305,782	32,265,431	23,508,791	Mar 30 08:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 27 '26	Buy	6.43	2,495,623	16,046,856	26,004,414	Mar 30 08:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 30 '26	Buy	6.50	971,091	6,312,092	26,975,505	Mar 30 08:30 PM
Francis Chris	See Remarks	Feb 26 '26	Option Exercise	4.28	33,194	141,920	79,767	Feb 27 09:00 PM
Francis Chris	See Remarks	Feb 26 '26	Sale	15.05	33,194	499,593	61,867	Feb 27 09:00 PM
Moran Kyle	Chief Financial Officer	Feb 09 '26	Sale	13.45	3,588	48,259	134,385	Feb 11 09:03 PM
BOLNO PAUL	President and CEO	Feb 09 '26	Sale	13.45	10,480	140,956	275,520	Feb 11 09:02 PM
Francis Chris	See Remarks	Feb 09 '26	Sale	13.45	1,883	25,326	61,867	Feb 11 09:01 PM
Vargeese Chandra	See Remarks	Feb 09 '26	Sale	13.45	3,228	43,417	408,246	Feb 11 09:00 PM
KYLE MORAN	Officer	Feb 09 '26	Proposed Sale	13.45	3,564	47,936		Feb 09 09:30 PM
Chris Francis	Officer	Feb 09 '26	Proposed Sale	13.45	1,870	25,152		Feb 09 09:29 PM
PAUL BOLNO	Officer	Feb 09 '26	Proposed Sale	13.45	10,411	140,028		Feb 09 09:27 PM
Francis Chris	See Remarks	Jan 02 '26	Option Exercise	3.14	9,375	29,438	34,375	Jan 06 09:30 PM
Francis Chris	See Remarks	Jan 02 '26	Sale	16.03	9,375	150,260	25,000	Jan 06 09:30 PM
GSK plc	10% Owner	Dec 11 '25	Buy	19.00	1,470,000	27,930,000	18,245,691	Dec 15 04:32 PM
Rawcliffe Adrian	Director	Dec 08 '25	Option Exercise	5.97	42,000	250,740	54,700	Dec 10 09:45 PM
Rawcliffe Adrian	Director	Dec 08 '25	Sale	15.00	42,000	630,000	12,700	Dec 10 09:45 PM
Wagner Heidi L	Director	Dec 08 '25	Option Exercise	5.97	14,000	83,580	51,930	Dec 10 09:45 PM
Wagner Heidi L	Director	Dec 08 '25	Sale	13.50	14,000	189,000	44,930	Dec 10 09:45 PM
HENRY CHRISTIAN O	Director	Dec 08 '25	Option Exercise	5.07	87,000	440,790	54,700	Dec 10 09:45 PM
HENRY CHRISTIAN O	Director	Dec 08 '25	Sale	14.65	93,445	1,369,324	12,700	Dec 10 09:45 PM
Tan Aik Na	Director	Dec 08 '25	Option Exercise	4.85	119,230	578,270	70,400	Dec 10 09:45 PM
Tan Aik Na	Director	Dec 08 '25	Sale	13.58	134,218	1,823,158	25,400	Dec 10 09:45 PM
Verdine Gregory L.	Director	Dec 08 '25	Sale	13.47	20,000	269,461	275,217	Dec 10 09:45 PM
Francis Chris	See Remarks	Dec 08 '25	Option Exercise	4.78	441,031	2,107,183	147,349	Dec 10 09:45 PM
Francis Chris	See Remarks	Dec 08 '25	Sale	14.57	441,031	6,427,085	25,000	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 09 '25	Option Exercise	9.51	86,000	818,120	139,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 08 '25	Option Exercise	3.43	210,000	721,300	189,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 08 '25	Sale	14.77	210,000	3,102,000	89,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 09 '25	Sale	20.03	50,036	1,001,979	89,218	Dec 10 09:45 PM
CORRIGAN MARK	Director	Dec 08 '25	Sale	13.48	16,115	217,297	28,815	Dec 10 09:45 PM
KYLE MORAN	Officer	Dec 09 '25	Proposed Sale	18.52	86,000	1,592,720		Dec 09 04:24 PM
Henry Family Trust	Affiliate	Dec 08 '25	Proposed Sale	18.52	93,445	1,730,601		Dec 08 07:08 PM
HEIDI L WAGNER	Director	Dec 08 '25	Proposed Sale	7.49	14,000	104,860		Dec 08 04:39 PM
KYLE MORAN	Officer	Dec 08 '25	Proposed Sale	7.49	210,000	1,572,900		Dec 08 04:37 PM
CHRISTOPHER FRANCIS	Officer	Dec 08 '25	Proposed Sale	7.49	483,602	3,622,179		Dec 08 04:36 PM
GREGORY VERDINE	Director	Dec 08 '25	Proposed Sale	7.49	20,000	149,800		Dec 08 04:35 PM
ADRIAN RAWCLIFFE	Director	Dec 08 '25	Proposed Sale	7.49	42,000	314,580		Dec 08 04:34 PM
MARK CORRIGAN	Director	Dec 08 '25	Proposed Sale	7.49	16,115	120,701		Dec 08 04:34 PM
AIK NA TAN	Director	Dec 08 '25	Proposed Sale	13.58	134,218	1,823,158		Dec 08 04:29 PM
Rawcliffe Adrian	Director	Nov 13 '25	Sale	6.79	16,115	109,421	12,700	Nov 14 09:00 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 13 '25	Buy	6.69	1,000	6,688	18,203,009	Nov 14 06:14 PM
ADRIAN RAWCLIFFE	Director	Nov 13 '25	Proposed Sale	6.96	16,115	112,080		Nov 13 04:25 PM
Verdine Gregory L.	Director	Aug 22 '25	Sale	10.00	10,000	100,000	285,217	Aug 26 09:40 PM
BOLNO PAUL	President and CEO	Aug 22 '25	Sale	10.10	217,351	2,194,810	121,000	Aug 26 09:40 PM
PAUL BOLNO	Director	Aug 22 '25	Proposed Sale	9.76	217,351	2,121,346		Aug 22 04:41 PM
GREGORY VERDINE	Director	Aug 22 '25	Proposed Sale	9.76	25,000	244,000		Aug 22 04:38 PM
Tan Aik Na	Director	Aug 15 '25	Option Exercise	9.13	21,000	191,730	61,388	Aug 19 08:00 PM
Tan Aik Na	Director	Aug 15 '25	Sale	9.25	21,000	194,250	40,388	Aug 19 08:00 PM
AIK NA TAN	Director	Aug 15 '25	Proposed Sale	9.25	21,000	194,250		Aug 15 04:59 PM
HENRY CHRISTIAN O	Director	Aug 13 '25	Sale	8.81	9,670	85,193	29,645	Aug 13 08:00 PM
Christian Henry	Director	Aug 13 '25	Proposed Sale	7.70	9,670	74,459		Aug 13 04:02 PM
TAKANASHI KEN	Director	Aug 05 '25	Sale	8.75	4,872	42,630	5,716,303	Aug 07 08:00 PM
Tan Aik Na	Director	Aug 05 '25	Sale	8.75	1,127	9,861	14,988	Aug 07 08:00 PM
Verdine Gregory L.	Director	Jun 13 '25	Sale	6.95	30,000	208,500	282,517	Jun 13 08:00 PM
GREGORY VERDINE	Director	Jun 13 '25	Proposed Sale	7.20	30,000	216,000		Jun 13 04:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WVE

Wave Life Sciences Ltd

Upgrade your Finviz experience